Will MRG’s report into growth in the German Left Atrial Appendage Occlusion market be a best seller. Bit nichey perhaps, but an indicator of the potential for the procedure.
Boston Scientific
Boston Acquires Cameron’s Leadless ICD In Potential Billion Dollar Deal
How much!? Boston Scientific must have done the maths in their decision to acquire Cameron Health and its leadless ICD device for what may end up being $1.35Bn dependent on reaching milestones over the next several years.
First FDA Clearance For Drug-Eluting Coronary Stent Use In Heart Attack Patients
Boston’s drug-eluting stents have become the first to gain FDA clearance for use in heart attack patients.
Boston’s WallFlex® Enteral Stents Gain Clinical Support
Boston Scientific is sounding pretty pleased with itself as it publicises positive results from three major studies on its WallFlex® enteral stent family of products.
J&J Loses Current Round In Drug Eluting Stent Patent Lawsuit With Medtronic, Abbott and Boston Scientific
You say sirolimus, I say everolimus… judge says lets call the whole thing off.
Uro/Gyne Surgical Mesh Implants: FDA Updates Position
FDA has announced a heightened degree of scrutiny regarding transvaginally inserted meshes and is considering reclassifying from Class II to Class III.
FDA Wants Shrinkage Warning on Boston Scientific’s Newly Approved Promus Element™ Stent
Boston Scientific’s Promus Element Drug Eluting Stent was approved by FDA in late November and now the agency has demanded that the company includes a warning on its packaging about the risk of stent shrinkage.
Two New Products From Boston Scientific
Boston Scientific launchea CHARGER™ PTA Balloon catheter in USA and Infinion 16, first and only 16-contact percutaneous lead for treatment of patients suffering chronic pain.
Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System
Boston Scientific has announced that it has received U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.
Boston’s WATCHMAN® Device First Patients in Latin America
Boston Scientific’s Innovative Watchman left atrial appendage closure device, a proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke, has been implanted for the first time in Latin America.
Stent Shrinkage Still In Spotlight. FDA Wades In.
FDA is taking a proactive stance and working with manufacturers to understand the issue of longitudinal compression in next generation Drug-Eluting Stents.
Boston Scientific Now Exclusively Marketing Catheter Robotics Amigo™ Remote Catheter System in Europe
Boston Scientific is beginning to market the CRI Amigo™ system, a remote-controlled catheter system, and related accessories in select European countries through an exclusive agreement with Catheter Robotics, Inc.
Medtronic Resolute® Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease
Pooled Data Analyses to Be Presented at TCT 2011 Demonstrate Heart Device’s Consistently Positive Performance Across Multiple Clinical Studies
Longitudinal Compression in Drug-Eluting Stents on the Agenda
Longitudinal Compression of Drug Eluting Stents with resultant potential shrinkage will be reviewed at the Transcatheter Cardiovascular Therapeutics meeting in San Francisco next week
Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments
Boston Scientific has introduced its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases.
Boston Scientific Completes Enrollment in International Benign Stricture Study of WallFlex® Biliary RX Stent
Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.